PASW Company Profile and Key Details

PASW has shown weak momentum, losing -35.64% over the past week and -76.05% over the past quarter, though year-to-date performance is down -63.59%. Short-term trend indicators are bullishly aligned (SMA20 -21.67%, SMA50 -51.19%, SMA200 -80.89%). The stock’s 14-day RSI is 34.98 (weak momentum), while the ATR of 0.04 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -97.04% below its high and over 10.57% above its low. Average 10-day trading volume of 164.88 thousand shares is below the 3-month average of 227.03 thousand, indicating normal recent market interest.

Ping An Biomedical Co., Ltd. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.32. This means the shares are trading below this model’s fair value.

The stock is currently mid-range between its 52-week high and low $0.12 and $5.40. With a market capitalization of about $2.89 million, Ping An Biomedical Co., Ltd. is classified as a micro-cap and shows higher-than-market volatility (beta ~2.51). Key stats such as the average daily volume over the past year has been around 279.15 thousand shares, volume is running light vs its 52-week average. Headquartered in Hong Kong, None, Ping An Biomedical Co., Ltd. operates in the Industrials sector and the Industrial - Distribution industry. Led by CEO Pijun Liu, the company employs approximately 7 people and listed since July 18, 2025. Ping An Biomedical Co., Ltd. engages in the provision of supply chain management services in the apparel industry delivering one-stop solutions to customers for a broad range of yarn products, textiles, and finished garments.

Ping An Biomedical Co., Ltd. (NASDAQ:PASW) shares are down -63.59% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Ping An Biomedical Co., Ltd. trading at a premium to the broader market with a P/E of 0.0. Our AI forecast model points to short-term weakness (-3.85% over two weeks), a medium-term fall (-93.59% over three months), and a longer-term loss (-74.36% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Ping An Biomedical Co., Ltd. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -3.85%, with price expected at $0.15 by June 11, 2026, within a range of $0.15 to $0.16 3-Month Outlook: Projected fall of -93.59%, reaching $0.01 by August 26, 2026, with a range of $0.00 to $0.02. 1-Year Outlook: Projected loss of -74.36%, with price at $0.04 by May 28, 2027, within a range of $0.03 to $0.05.

Ping An Biomedical Co., Ltd. trades at a P/E ratio of 0.0, slightly below the S&P 500 average, with a price-to-sales ratio of 0.22 The P/FCF stands at 1.34, also above market averages.